<DOC>
	<DOCNO>NCT02497638</DOCNO>
	<brief_summary>This study randomize trial examine administration combination biguanide metformin atorvastatin ( `` Lipitor '' ) men experience rise prostate-specific antigen ( PSA ) level , despite undergone radical therapy ( surgery and/or radiation ) .</brief_summary>
	<brief_title>LIpitor biGuanide Androgen Delay Trial</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Willing able provide inform consent Histologically confirm adenocarcinoma prostate History radical therapy ( i.e. , radical prostatectomy , radiotherapy , brachytherapy prostatectomy salvage radiotherapy ) Serum testosterone level 8.0 nmol/L ( 230 ng/dL ) great Not currently undergo treatment hyperlipidemia diabetes mellitus LDLcholesterol level 5 mmol/L low HgA1c 6.5 % low PSA level 2 5 ng/mL Subjects treat prostate cancer follow : i. Cytotoxic chemotherapy ; ii . Hormonal therapy within past 3 year ; iii . Oral glucocorticoid ; iv . Gonadotropinreleasing hormone ( GnRH ) analogue ( e.g. , leuprolide , goserelin , degarelix ) Past treatment 5Î± reductase inhibitor finasteride dutasteride within past 5 year Past treatment drug antiandrogenic property ( e.g. , flutamide , bicalutamide , ketoconazole , progestational agent ) within 6 month prior screen Use metformin statin within past 2 year Planned concurrent use metformin , sulfonylurea , thiazolidinediones insulin reason Known hypersensitivity intolerance metformin atorvastatin Any clinically significant laboratory abnormality ( e.g. , severe renal hepatic impairment ) judgment investigator would affect patient 's health outcome trial Any condition associate increase risk metforminassociated lactic acidosis ( e.g. , congestive heart failure define New York Heart Association ( NYHA ) class III IV , history type acidosis , habitual intake 4 alcoholic beverage per day ) Abnormal liver function test Abnormal organ marrow function</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>metformin</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>prostate-specific antigen</keyword>
	<keyword>biochemical recurrence</keyword>
</DOC>